Corcept Therapeutics Inc
CORTNasdaqCIK 1088856HealthcareFiscal year ends Dec 31
Reports and events: 300 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2308:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-398561 |
| 2026-07-2916:09 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-050613 |
| 2026-07-2916:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-050607 |
| 2026-06-1716:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-274258 |
| 2026-06-0308:00 ET | 8-K | 8.01 Other events | 0001193125-26-254622 |
| 2026-05-2816:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-038793 |
| 2026-04-3016:14 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-028902 |
| 2026-04-3016:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-028892 |
| 2026-04-1716:08 ET | DEF 14A | Proxy statementPeriod 2026-04-17 | 0001628280-26-025735 |
| 2026-03-2513:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-123543 |
| 2026-02-2416:13 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-011091 |
| 2026-02-2416:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-011080 |
| 2026-02-1916:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-059551 |
| 2026-01-2208:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-018704 |
| 2025-12-3114:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-338184 |
| 2025-11-0416:12 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-048841 |
| 2025-11-0416:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001628280-25-048814 |
| 2025-10-1406:02 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-237834 |
| 2025-10-0616:36 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-231963 |
| 2025-09-1008:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-199706 |
| 2025-07-3116:10 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-037005 |
| 2025-07-3116:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001628280-25-036999 |
| 2025-07-1408:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-158454 |
| 2025-06-1616:47 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-25-031624 |
| 2025-05-0516:09 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-022173 |
| 2025-05-0516:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-022167 |
| 2025-04-2516:11 ET | DEF 14A | Proxy statementPeriod 2025-04-25 | 0001628280-25-019942 |
| 2025-03-3108:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-067871 |
| 2025-03-0316:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-044123 |
| 2025-02-2616:18 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-008167 |
| 2025-02-2616:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-008131 |
| 2024-12-3017:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-286917 |
| 2024-10-3016:12 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-044322 |
| 2024-10-3016:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-044318 |
| 2024-07-2916:13 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-033284 |
| 2024-07-2916:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-033281 |
| 2024-05-2316:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-024936 |
| 2024-05-0116:12 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-019610 |
| 2024-05-0116:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-019607 |
| 2024-04-1706:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-098492 |
| 2024-04-1016:43 ET | DEF 14A | Proxy statementPeriod 2024-04-10 | 0001628280-24-015633 |
| 2024-02-1516:17 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-005055 |
| 2024-02-1516:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-005048 |
| 2024-01-0808:06 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-003933 |
| 2024-01-0208:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-000247 |
| 2023-12-1116:34 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-23-292621 |
| 2023-11-0116:16 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628280-23-035988 |
| 2023-11-0116:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-035979 |
| 2023-08-0216:14 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001628280-23-026768 |
| 2023-08-0216:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-026757 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:31 ET. Listed shows no prices and gives no investment advice.